Lipocine registers Phase 3 study of oral LPCN 1154A for postpartum depressionSep 16Trial updatebrexanoloneLipocine Inc.
Lipocine's PPD drug misses Phase 3 goal, but company cites site data anomaliesAug 4Quarterly updateLipocine Inc.
Sign inSign in